Takeda Pharmaceutical
TAK
#469
Rank
โ‚ฌ40.94 B
Marketcap
12,91ย โ‚ฌ
Share price
0.37%
Change (1 day)
1.06%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2024 (TTM): โ‚ฌ27.15 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚ฌ27.78 Billion. In 2023 the company made a revenue of โ‚ฌ26.54 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ27.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ27.15 B2.27%
2023 โ‚ฌ26.54 B-3.78%
2022 โ‚ฌ27.59 B0.95%
2021 โ‚ฌ27.33 B11.41%
2020 โ‚ฌ24.53 B-7.47%
2019 โ‚ฌ26.51 B87.86%
2018 โ‚ฌ14.11 B6.48%
2017 โ‚ฌ13.25 B-12.91%
2016 โ‚ฌ15.21 B9.72%
2015 โ‚ฌ13.87 B4.77%
2014 โ‚ฌ13.23 B9.64%
2013 โ‚ฌ12.07 B-17.04%
2012 โ‚ฌ14.55 B2.12%
2011 โ‚ฌ14.25 B15.46%
2010 โ‚ฌ12.34 B13.94%
2009 โ‚ฌ10.83 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ83.15 B 199.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.73 B 82.57%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ52.75 B 89.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.35 B 70.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ2.18 B-92.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.28 B-88.18%๐Ÿ‡ฎ๐Ÿ‡ณ India
โ‚ฌ30.84 B 11.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.16 B 37.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ59.24 B 113.19%๐Ÿ‡บ๐Ÿ‡ธ USA